369 related articles for article (PubMed ID: 10894150)
1. Unliganded and liganded estrogen receptors protect against cancer invasion via different mechanisms.
Platet N; Cunat S; Chalbos D; Rochefort H; Garcia M
Mol Endocrinol; 2000 Jul; 14(7):999-1009. PubMed ID: 10894150
[TBL] [Abstract][Full Text] [Related]
2. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
Gougelet A; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
[TBL] [Abstract][Full Text] [Related]
5. Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.
Saville B; Poukka H; Wormke M; Janne OA; Palvimo JJ; Stoner M; Samudio I; Safe S
J Biol Chem; 2002 Jan; 277(4):2485-97. PubMed ID: 11696545
[TBL] [Abstract][Full Text] [Related]
6. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
[TBL] [Abstract][Full Text] [Related]
7. Role of estrogens and their receptors in adhesion and invasiveness of breast cancer cells.
Maynadier M; Nirdé P; Ramirez JM; Cathiard AM; Platet N; Chambon M; Garcia M
Adv Exp Med Biol; 2008; 617():485-91. PubMed ID: 18497073
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor (ER)-mediated transcriptional regulation of the human corticotropin-releasing hormone-binding protein promoter: differential effects of ERalpha and ERbeta.
van de Stolpe A; Slycke AJ; Reinders MO; Zomer AW; Goodenough S; Behl C; Seasholtz AF; van der Saag PT
Mol Endocrinol; 2004 Dec; 18(12):2908-23. PubMed ID: 15345745
[TBL] [Abstract][Full Text] [Related]
9. Increases in estrogen receptor-alpha concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen.
Fowler AM; Solodin N; Preisler-Mashek MT; Zhang P; Lee AV; Alarid ET
FASEB J; 2004 Jan; 18(1):81-93. PubMed ID: 14718389
[TBL] [Abstract][Full Text] [Related]
10. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.
Zou A; Marschke KB; Arnold KE; Berger EM; Fitzgerald P; Mais DE; Allegretto EA
Mol Endocrinol; 1999 Mar; 13(3):418-30. PubMed ID: 10076999
[TBL] [Abstract][Full Text] [Related]
12. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells.
Stoica A; Pentecost E; Martin MB
Endocrinology; 2000 Oct; 141(10):3595-602. PubMed ID: 11014213
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
14. The N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells.
Rousseau C; Pettersson F; Couture MC; Paquin A; Galipeau J; Mader S; Miller WH
J Steroid Biochem Mol Biol; 2003 Jul; 86(1):1-14. PubMed ID: 12943740
[TBL] [Abstract][Full Text] [Related]
15. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
16. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
Trauernicht AM; Kim SJ; Kim NH; Boyer TG
Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
[TBL] [Abstract][Full Text] [Related]
17. 17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells.
Sisci D; Middea E; Morelli C; Lanzino M; Aquila S; Rizza P; Catalano S; Casaburi I; Maggiolini M; Andò S
Breast Cancer Res Treat; 2010 Nov; 124(1):63-77. PubMed ID: 20052536
[TBL] [Abstract][Full Text] [Related]
18. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
Power KA; Thompson LU
Breast Cancer Res Treat; 2003 Oct; 81(3):209-21. PubMed ID: 14620916
[TBL] [Abstract][Full Text] [Related]
19. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions.
Webb P; Nguyen P; Valentine C; Lopez GN; Kwok GR; McInerney E; Katzenellenbogen BS; Enmark E; Gustafsson JA; Nilsson S; Kushner PJ
Mol Endocrinol; 1999 Oct; 13(10):1672-85. PubMed ID: 10517669
[TBL] [Abstract][Full Text] [Related]
20. Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor.
Lin KH; Wang WJ; Wu YH; Cheng SY
Endocrinology; 2002 Feb; 143(2):467-75. PubMed ID: 11796500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
